Final Programme - World Heart Federation

industry sAteLLite syMPosiA And WorksHoP ACtivities - intersession
tuesday, 20 May 2008
missouRi - yelloW Pavillion - 12:30-13:30
Symposium (IS)
Bayer Schering Pharma AG
management of Right ventRiCulaR dysfunCtion in
PulmonaRy aRteRial hyPeRtension
Chairs: Miguel Gomez Sanchez (SPAIN), Sergio Perrone (ARGENTINA)
12:30 RV function in pulmonary hypertension
Sandrine Huez (BELGIUM)
12:45 How should we evaluate right ventricular function?
Adam Torbicki (POLAND)
13:00 Chronic adaptation of right ventricular function: Eisenmenger syndrome
Julio Sandoval (ARGENTINA)
13:15 Management of right ventricular dysfunction
Stephan Rosenkranz (GERMANY)
seine - gReen Pavillion - 12:30-13:30
Symposium (IS)
Merck KGaA
the Weight of the evidenCe: setting the standaRd With beta-bloCkade
Chair: Norberto Vulcano (ARGENTINA)
12:30 Beta-blockade in chronic heart failure (CHF): past, presence and future of beta-blockers in CHF management
Cagide Arturo (ARGENTINA)
12:42 Beta-blockade in chronic heart failure (CHF): CIBIS III - expanding the frontier
Piotr Ponikowski (POLAND)
12:54 Cardioprotection in non-cardiac surgery (NCS):perioperative management in NCS - current status
Anai Durazzo (BRAZIL)
13:06 Cardioprotection in non-cardiac surgery (NCS): recent advances with beta-blockade in NCS
Don Poldermans (NETHERLANDS)
13:18 Closing remarks
Piotr Ponikowski (POLAND)